Effects of memantine and MK-801 on NMDA-induced currents in cultured neurones and on synaptic transmission and LTP in area CA1 of rat hippocampal slices
about
Ephenidine: A new psychoactive agent with ketamine-like NMDA receptor antagonist propertiesPharmacodynamics of memantine: an update.An N-methyl-D-aspartate receptor channel blocker with neuroprotective activity.Spatial relationship between synapse loss and beta-amyloid deposition in Tg2576 mice.Memantine improves cognition and reduces Alzheimer's-like neuropathology in transgenic mice.Pathologically activated neuroprotection via uncompetitive blockade of N-methyl-D-aspartate receptors with fast off-rate by novel multifunctional dimer bis(propyl)-cognitin.Apoptosis modulators in the therapy of neurodegenerative diseases.The NMDA receptor as a target for cognitive enhancementRegion-specific role for GluN2B-containing NMDA receptors in injury to Purkinje cells and CA1 neurons following global cerebral ischemia.The role of the N-methyl-D-aspartate receptor in Alzheimer's disease: therapeutic potential.Effects of memantine on recombinant rat NMDA receptors expressed in HEK 293 cellsKetamine Protects Gamma Oscillations by Inhibiting Hippocampal LTDContribution of N-methyl-D-aspartate receptors to attention and episodic spatial memory during senescence.Timosaponin derivative YY-23 acts as a non-competitive NMDA receptor antagonist and exerts a rapid antidepressant-like effect in miceA brief review of the pharmacologic and therapeutic aspects of memantine in Alzheimer's disease.Advances in hemorrhagic stroke therapy: conventional and novel approaches.Indistinguishable synaptic pharmacodynamics of the N-methyl-D-aspartate receptor channel blockers memantine and ketamine.NMDA receptor as a newly identified member of the metabotropic glutamate receptor family: clinical implications for neurodegenerative diseases.Alzheimer's disease amyloid beta-protein and synaptic function.Extrasynaptic NMDA Receptor in Excitotoxicity: Function Revisited.Current pharmacotherapy and putative disease-modifying therapy for Alzheimer's disease.AZD1080, a novel GSK3 inhibitor, rescues synaptic plasticity deficits in rodent brain and exhibits peripheral target engagement in humans.Blocking kinetics of memantine on NR1a/2A receptors recorded in inside-out and outside-out patches from Xenopus oocytes.Testing NMDA receptor block as a therapeutic strategy for reducing ischaemic damage to CNS white matter.Memantine block depends on agonist presentation at the NMDA receptor in substantia nigra pars compacta dopamine neurones.Neramexane: a moderate-affinity NMDA receptor channel blocker: new prospects and indications.L-687,414, a low efficacy NMDA receptor glycine site partial agonist in vitro, does not prevent hippocampal LTP in vivo at plasma levels known to be neuroprotective.Role of ionotropic glutamate receptors in delay and probability discounting in the rat.Activation of Fyn tyrosine kinase in the mouse dorsal hippocampus is essential for contextual fear conditioning.Neuroprotective and symptomatological action of memantine relevant for Alzheimer's disease--a unified glutamatergic hypothesis on the mechanism of action.Use of behavioural and long-term potentiation models in the development of memory-improving drugs.The Neuropharmacological Basis for the Use of Memantine in the Treatment of Alzheimer's Disease
P2860
Q28820763-2A62A810-0268-44CD-BF70-B264E2B1DC31Q30490604-271B11D1-71F7-49FF-9395-083191B538D9Q30983394-01F98364-A9DF-4D50-88D7-2D2AD9538954Q33263907-71A4ECD6-EF1C-4214-803A-B9362C908238Q33597194-B80C936C-53AB-4734-ADF3-6E3E9A0C8573Q33924304-8911B47E-BD12-452E-9194-97D3C190180AQ34074800-6281AC93-69CC-4060-94D0-06C990DA94C3Q34288139-10189237-D3C3-4789-8E3E-F2FCE66B8D1DQ34714442-51EA00D2-4AB6-45E9-98C3-9F7C07575F9FQ35197783-48C4F555-7AC0-4B42-BE81-A09ACD4C1756Q35884655-08C59130-223D-4A90-AA2F-3D0C01868B91Q36088786-C1142AA2-6049-4286-83E5-805BD61383CAQ36289349-551529A8-A1D3-439D-B834-DE3C045E80E1Q36579258-70A352BC-F4E7-4C4F-8C01-AF7DA6FBDAF2Q36725234-E0145680-36A5-436B-AF16-6724313E7A97Q36944012-93E2631D-F4DB-4568-ABDA-91A26B5D9528Q37325648-D2D33CA6-3AAD-4459-A31A-CAF2E29EC3E6Q37462558-242897AA-0D40-4388-A757-7B3C9B14B89AQ37598118-AA16613E-0F6E-4B29-A265-3DE704BADF48Q38244299-66F5968E-F66A-4839-BBF7-EB6F40DC369BQ38850493-74539C84-3EB0-4299-9C1C-645DAD6A5C6BQ39194419-6B0D9D09-53F4-49A1-B057-E69B7E97FA3DQ39317427-40FEA598-7DD5-40AF-867C-603E256AD2B4Q40315187-58EF32D6-D0B5-4572-AAB1-F877D8224BE4Q42044413-B6DB917C-163C-49DF-883C-FAA7E82C73C0Q42637057-FE2403BE-8E72-4930-ADB6-FD71BFE0CF9CQ43185141-4BD8EAD4-5BA7-40AB-9922-A08E5073A8FAQ43188052-3A9C8D84-99C8-46DF-B3B5-6CF5C2CCC289Q46437578-8F497845-D135-46CF-AA64-47225A3A1F4DQ48491954-6161B6F5-4D4D-45BC-B90E-A42A9F82798BQ51962312-53B8AAAA-D193-4BD3-A6F1-8155143424BFQ56484985-36C60B86-BFB4-44B6-A28E-EC95F6F3CE10
P2860
Effects of memantine and MK-801 on NMDA-induced currents in cultured neurones and on synaptic transmission and LTP in area CA1 of rat hippocampal slices
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
1996年论文
@zh
1996年论文
@zh-cn
name
Effects of memantine and MK-80 ...... CA1 of rat hippocampal slices
@ast
Effects of memantine and MK-80 ...... CA1 of rat hippocampal slices
@en
type
label
Effects of memantine and MK-80 ...... CA1 of rat hippocampal slices
@ast
Effects of memantine and MK-80 ...... CA1 of rat hippocampal slices
@en
prefLabel
Effects of memantine and MK-80 ...... CA1 of rat hippocampal slices
@ast
Effects of memantine and MK-80 ...... CA1 of rat hippocampal slices
@en
P2093
P2860
P1476
Effects of memantine and MK-80 ...... CA1 of rat hippocampal slices
@en
P2093
Collingridge GL
Frankiewicz T
Parsons CG
P2860
P304
P356
10.1111/J.1476-5381.1996.TB15245.X
P407
P577
1996-02-01T00:00:00Z